SCHEMBL1006972

SCHEMBL1006972

CC1(C)CCC([O])CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL743279 0.81
SCHEMBL424258 0.69
SCHEMBL18791181 0.69
SCHEMBL8397539 0.68
SCHEMBL5432 0.68
SCHEMBL8095966 0.67 MAPT (0.32)
SCHEMBL1782649 0.67
SCHEMBL23169287 0.67
SCHEMBL424257 0.67
SCHEMBL43449 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4195042-A Rhodium hydroformylation catalyst PHILLIPS PETROLEUM COMPANY (US) 1980-03-25 US claimed
US-3956177-A Rhodium hydroformylation catalyst PHILLIPS PETROLEUM COMPANY (US) 1976-05-11 US claimed
US-20230190943-A1 ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2023-06-22 US disclosed
EP-3770180-A1 ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND Mochida Pharmaceutical Co., Ltd. (JP) 2021-01-27 EP disclosed
US-20210000968-A1 ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2021-01-07 US disclosed
WO-2019189419-A1 ANTI-CANCER AGENT-BONDED ALGINIC ACID DERIVATIVE 持田製薬株式会社 2019-10-03 WO disclosed
US-20150266839-A1 CYCLIC AMIDE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-09-24 US disclosed
US-20150225392-A1 CYCLIC AMIDE DERIVATIVE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-08-13 US disclosed
US-9072758-B2 Cyclic amide derivative MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-07-07 US disclosed
US-9040525-B2 Cyclic amide derivative MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2015-05-26 US disclosed
US-8765752-B2 3-hydroxyisothiazole 1-oxide derivatives MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2014-07-01 US disclosed
CN-102137837-A PAI-1 inhibitor INST MED MOLECULAR DESIGN INC 2011-07-27 CN disclosed
EP-2272817-A1 PAI-1 INHIBITOR Institute of Medicinal Molecular Design, Inc. (JP) 2011-01-12 EP disclosed
US-20090312315-A1 PAI-1 INHIBITOR INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2009-12-17 US disclosed
EP-0726266-B1 Indazole compounds and the use thereof as fungicides, insecticides and miticides MITSUBISHI CHEM CORP (JP) 1998-01-07 EP disclosed
US-5705453-A INSECTICIDES, MITICIDES, FUNGICIDES MITSUBISHI CHEMICAL CORPORATION (JP) 1998-01-06 US disclosed
CN-1137523-A Indazoles and use thereof MITSUBISHI CHEM CORP (JP) 1996-12-11 CN disclosed
EP-0726266-A1 Indazole compounds and the use thereof as fungicides, insecticides and miticides MITSUBISHI CHEMICAL CORPORATION (JP) 1996-08-14 EP disclosed
US-4195042-A Rhodium hydroformylation catalyst PHILLIPS PETROLEUM COMPANY (US) 1980-03-25 US disclosed
US-3956177-A Rhodium hydroformylation catalyst PHILLIPS PETROLEUM COMPANY (US) 1976-05-11 US disclosed